REBECCA: A Cohort Study of Regorafenib in the Real-life Setting in Patients Previously Treated for Metastatic Colorectal Cancer.
Phase of Trial: Phase IV
Latest Information Update: 10 Aug 2016
At a glance
- Drugs Regorafenib (Primary)
- Indications Colorectal cancer
- Focus Therapeutic Use
- Acronyms REBECCA
- 07 Jun 2017 Biomarkers information updated
- 08 Aug 2016 Status changed from active, no longer recruiting to completed.
- 07 Nov 2014 New trial record